Mike Catton

4.6k citations
34 papers · 2.5k indexed · 1 hit paper · h-index 17

Impact in

Papers in

    • SARS-CoV-2 and COVID-19 Research 12
    • SARS-CoV-2 detection and testing 8
    • COVID-19 Clinical Research Studies 6
    • Viral gastroenteritis research and epidemiology 3

Mike Catton

34 papers receiving 2.4k citations

Hit Papers

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro 2020 · 1.5k citations
1.5k20202026202220244008001.2k

Peers

Mike Catton
Comparison fields: 5 of 139
  • Infectious Diseases 1.8k
  • Applied Microbiology and Biotechnology 67
  • Modeling and Simulation 104
  • Neurology 319
  • Transplantation 52
Replace Payam Tabarsi with:
Payam Tabarsi Iran
Jenny G. Low Singapore
Delphine Martiny Belgium
Jingwen Ai China
Massimo Andreoni Italy
Thushan I. de Silva United Kingdom
Leon Caly Australia
Satoshi Kutsuna Japan
Sunil K. Lal India
Frederick G. Hayden United States
Mike Catton relative to Payam Tabarsi Iran Payam Tabarsi's profile →
Citations per field
00.5×8.7×
Payam Tabarsi · 1×
Citations per year

Countries citing papers authored by Mike Catton

Since Specialization
Citations

This map shows the geographic impact of Mike Catton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Catton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Catton more than expected).

Fields of papers citing papers by Mike Catton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Catton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Catton. The network helps show where Mike Catton may publish in the future.

Co-authors

The 25 scholars most cited alongside Mike Catton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mike Catton Line = papers co-authored together Mike Catton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Hit paper breakdown →
20201478
2 2020158
3 1998148
4 2007105
5 200693
6 200967
7 200260
8 200745
9 200242
10 202038
11 200930
12 202028
13 201628
14 202027
15 202021
16 200419
17 200516
18 202115
19 199915
20
Combined infection of Norwalk-like virus and verotoxin-producing bacteria associated with a gastroenteritis outbreak.
199912

About Mike Catton

Mike Catton is a scholar working on Infectious Diseases, General Dentistry, Modeling and Simulation, Transplantation and Epidemiology, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (8 papers), COVID-19 Clinical Research Studies (6 papers), Virology and Viral Diseases (6 papers), Biosensors and Analytical Detection (5 papers), Animal Virus Infections Studies (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and COVID-19 epidemiological studies (3 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Applied Microbiology and Biotechnology (67 citations), Modeling and Simulation (104 citations), Neurology (319 citations) and Transplantation (52 citations). Mike Catton has collaborated with scholars based in Australia, Singapore and United States. Frequent co-authors include Julian Druce, Leon Caly, Kylie M. Wagstaff, David A. Jans, Chris Birch, J Leydon, Thomas Tran, Doris Chibo, G J Becker and Kenneth G. C. Smith. Their work appears in journals such as The Medical Journal of Australia, Journal of Clinical Microbiology, Pathology, Antiviral Research and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026